Abstract
Male infertility is on the rise over the past few years, and azoospermia is one of the most common causes. It has two primary subtypes: non-obstructive azoospermia (NOA), where the spermatogenesis is hindered, and obstructive azoospermia (OA), when there appears to be a ductal obstruction while spermatogenesis is normal. Azoospermia is characterised by the absence of sperm in two or more ejaculates. Making the azoospermic man have his own biological child is now becoming a reality with the advent of TESE and ICSI procedures, followed by the latest advancements like the combination of imaging studies, Full-Field Optical Coherence Tomography (FFOCT), stem cell therapy, platelet-rich plasma therapy, and gene therapy, which are emerging as newer tools for effective treatment. The key aim of this article is to highlight the concept of azoospermia and focus on its evaluation and management through present-day developments in andrology and medically assisted reproduction (MAR). A detailed literature review is performed through Pubmed, Science Direct, the Online Library, and Scopus.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
